# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T00:24:16.068452
**Response ID:** resp_0998decfb95d175f00697a99b49a7c8194b9fc289488b5bb38
**Tokens:** 18805 in / 7081 out
**Response SHA256:** 2a2168151488623a

---

I checked the draft strictly for **fatal errors** in (1) data–design alignment, (2) regression sanity, (3) completeness, and (4) internal consistency.

## 1) Data–Design Alignment (critical)
- **Treatment timing vs data coverage:** Policies are adopted in **Aug 2022** and **Aug 2023**; data are **CPS-FSS 2022–2024**. So max(treatment year)=2023 ≤ max(data year)=2024. No impossibility.
- **Post-treatment observations:** For the **2023 cohort** (CO, MI, MN, NM), you have post observations in **2023 and 2024**; for **2022 adopters** you correctly note there is no clean pre-period within your limited 2022–2024 window and you exclude them from TWFE/C-S estimation. No design/data impossibility.
- **Treatment definition consistency:** Table 1’s adoption cohorting matches how later sections describe the restricted identifying sample (2023 adopters + never-treated). No direct contradiction found between Table 1 and the regression samples used for identification.

## 2) Regression Sanity (critical)
Checked Tables 3–6:
- No implausibly huge coefficients/SEs, no “NA/Inf/NaN,” no negative SEs, no impossible values reported.
- SE magnitudes are coherent for binary outcomes in percentage-point units.
- Fixed effects structure is consistent with reported identification (e.g., state×year FE absorbing main treatment effects in DDD).

## 3) Completeness (critical)
- Regression tables report **N**, FE structure, and SE/CI where claimed.
- All tables/figures referenced in the provided draft segment (Tables 1–6; Figures 1–5) appear to exist (no missing referenced objects in what you shared).
- No placeholders (“TBD”, “TODO”, etc.) found.

## 4) Internal Consistency (critical)
- Key numbers cited in text/abstract match the corresponding tables (e.g., TWFE 0.047 with SE 0.020 and CI [0.009, 0.085]; DDD −0.008 with SE 0.013 and CI [−0.034, 0.018]; RI p-value 0.015).
- Sample definitions are consistent across the TWFE/C-S/DDD sections (46 state/DC units → 138 state-year cells over 2022–2024).

ADVISOR VERDICT: PASS